Krystal Biotech's investigational topical gene therapy has shown promise in DEB. It is designed to deliver COL7A1 and restore C7 protein in patients with the rare disorder.
Heidi Anne Duerr, MPH
Advertisement
Articles by Heidi Anne Duerr, MPH
Advertisement
Latest Updated Articles
B-VEC Shows Quality of Life Improvements in Dystrophic Epidermolysis BullosaPublished: March 27th 2023 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
CARsgen’s CAR-T Satri-Cel Significantly Reduces CA19-9 Levels in Patients With Pancreatic Ductal Adenocarcinoma
2
Around the Helix: Cell and Gene Therapy Company Updates – October 22, 2025
3
AskBio’s Heart Failure Gene Therapy AB-1002 Shows Ability to Improve NYHA Class in Phase 1 Trial
4
